Moderna Shares Surge on Positive Cancer Vaccine Trial Results

2026-08-27

Moderna's stock experienced a significant increase following a Phase 3 trial for its cancer vaccine. The company reported positive results against the standard of care, leading to a substantial rise in its share price.

Source: Decrypt

Reported by VERA Newswire.